{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALPMF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALPMF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMF\",,,,,undefined,":{"symbol":"ALPMF","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":9.3585,"timestamp":1748635005051,"preClose":9.3585,"halted":0,"volume":1,"delay":15,"floatShares":1731101601,"shares":1861787075,"eps":0.074352,"marketStatus":"Market Closed","change":0,"latestTime":"05-30 15:56:45 EDT Delay","open":9.3585,"high":9.3585,"low":9.3585,"amount":9.96,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1748851200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":9.3585,"volumeRatio":0.00011158721432716272},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMF\",,,,,undefined,":{"symbol":"ALPMF","floatShares":1731101601,"roa":"4.21%","roe":"3.26%","lyrEps":0.062841,"volumeRatio":0.00011158721432716272,"shares":1861787075,"dividePrice":0.513708,"high":9.3585,"amplitude":0,"preClose":9.3585,"low":9.3585,"week52Low":8.405,"pbRate":"1.66","psRate":"1.31","week52High":12.74,"institutionHeld":0,"latestPrice":9.3585,"eps":0.074352,"divideRate":0.054892,"volume":1,"delay":15,"ttmEps":0.074352,"open":9.3585,"prevYearClose":9.86,"prevWeekClose":9.55,"prevMonthClose":9.3585,"prevQuarterClose":9.75,"fiveDayClose":9.55,"twentyDayClose":10.12,"sixtyDayClose":9.7951},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ALPMF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALPMF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540784331","title":"Morgan Stanley Sticks to Its Hold Rating for Astellas Pharma (ALPMF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540784331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540784331?lang=en_us&edition=fundamental","pubTime":"2025-06-01 00:55","pubTimestamp":1748710517,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Shinichiro Muraoka from Morgan Stanley maintained a Hold rating on Astellas Pharma (ALPMF – Research Report), with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-astellas-pharma-alpmf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-astellas-pharma-alpmf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALPMF"],"gpt_icon":0},{"id":"2532607777","title":"Astellas to Present New Data in Geographic Atrophy at Upcoming Ophthalmology Annual Congresses","url":"https://stock-news.laohu8.com/highlight/detail?id=2532607777","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532607777?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:00","pubTimestamp":1746104400,"startTime":"0","endTime":"0","summary":"ARVO andRWC abstracts feature analyses on biomarkers, mechanism of disease, patient experience and other data fromIZERVAY pivotal studies. TOKYO, May 1, 2025 /PRNewswire/ -- Astellas Pharma Inc. , maker of IZERVAY, a C5 inhibitor for the treatment of geographic atrophy *, will highlight new data that enhances continued understanding of the science of GA, and the experience of patients living with the progressive disease at the Association for Research in Vision and Ophthalmology Annual Meeting , May 4-8, Salt Lake City, Utah, and Retina World Congress , May 8-11, Fort Lauderdale, Florida.The data comprises nine abstracts, including two oral presentations, featuring analyses on biomarkers, patient experience, mechanism of disease and other insights from the GATHER Phase 3 studies ofIZERVAY for the treatment of GA secondary to age-related macular degeneration .Marci English, Senior Vice President, Biopharma and Ophthalmology Development, Astellas Pharma\"Recognizing the early indicators a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/astellas-present-data-geographic-atrophy-130000768.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astellas-present-data-geographic-atrophy-130000768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4614","LU0823421333.USD","ALPMY","BK4529","BK4141","LU1303367103.USD","LU2250418816.HKD","LU1989764664.SGD","IE00BMPRXR70.SGD","IE0004445239.USD","LU0082616367.USD","LU0390134368.USD","LU2054465674.USD","RWC","LU0127658192.USD","LU2458330243.SGD","LU2098885051.SGD","ACP","IE00BMPRXN33.USD","BK4543","LU1852331112.SGD","LU0198837287.USD","LU2458330169.SGD","BK4007","BK4573","GFS","LU1951200564.SGD","LU2264538146.SGD","LU0109392836.USD","ALPMF","LU1923623000.USD","LU1988902786.USD","BK4575","BK4534","LU0719512351.SGD","BK4512","LU1880398554.USD","BK4588","LU1803068979.SGD","LU0642271901.SGD","LU0081259029.USD","LU0823421416.USD","LU1316542783.SGD","IE0009356076.USD","LU1242518857.USD","LU1242518931.SGD","LU0889565833.HKD","IE00B5949003.HKD","BK4605","LU1951198990.SGD"],"gpt_icon":1},{"id":"2531640807","title":"Astellas Pharma (ALPMY) Upgraded to Strong Buy: What Does It Mean for the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2531640807","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531640807?lang=en_us&edition=fundamental","pubTime":"2025-04-30 00:00","pubTimestamp":1745942410,"startTime":"0","endTime":"0","summary":"Astellas Pharma Inc.  could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 . This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for Astellas Pharma basically reflects positivity about its earnings outlook that could translate into buying pressure and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astellas-pharma-alpmy-upgraded-strong-160010586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALPMY","ALPMF"],"gpt_icon":0},{"id":"2517544503","title":"J.P. Morgan Remains a Hold on Astellas Pharma (ALPMF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517544503","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517544503?lang=en_us&edition=fundamental","pubTime":"2025-03-08 20:06","pubTimestamp":1741435619,"startTime":"0","endTime":"0","summary":"In a report released on March 5, Seiji Wakao from J.P. Morgan maintained a Hold rating on Astellas Pharma (ALPMF – Research Report), with a price t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-hold-on-astellas-pharma-alpmf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-hold-on-astellas-pharma-alpmf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALPMF","LU2347655156.SGD","LU0320765646.SGD","BK4516","LU2023251221.USD","LU0795875086.SGD","LU1720051017.SGD","LU2357305700.SGD","LU0267386448.USD","LU1363072403.SGD","LU2089283258.USD","LU0106261372.USD","LU0106831901.USD","LU2089284900.SGD","LU0912757837.SGD","LU0225283273.USD","LU1548497426.USD","LU1074936037.SGD","IE00BKVL7J92.USD","BK4585","LU0158827781.USD","BK4007","LU2271345857.HKD","LU1989772840.SGD","BK4588","LU0158827948.USD","LU1720051108.HKD","LU2133065610.SGD","LU1162221912.USD","BK4504","IE00BZ1G4Q59.USD","LU1732800096.USD","LU2111349929.HKD","LU1668664300.SGD","LU0006306889.USD","BK4581","LU1989772923.USD","LU2028103732.USD","LU0971096721.USD","BK4534","BK4127","LU0795875169.SGD","LU1732799900.SGD","LU0314104364.USD","LU0098860793.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-25","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null},{"date":"2023-09-28","symbol":"ALPMF","amount":35,"announcedDate":"2023-07-19","type":"dividend","market":"US","newRecordDate":"2023-09-30","defaultRemindTime":1695907800000,"name":"Astellas Pharma, Inc.","recordDate":"2023-12-01","payableDate":"2023-09-30","currency":"JPY","dateTimestamp":1695873600000,"payDate":"2023-12-01"},{"market":"US","date":"2023-08-01","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1690862400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMF\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-27","recordDate":"2019-03-31","paymentDate":"2019-06-18","value":19,"currency":"JPY"},{"executeDate":"2019-09-27","recordDate":"2019-09-30","paymentDate":"2019-12-03","value":20,"currency":"JPY"},{"executeDate":"2020-03-30","recordDate":"2020-03-31","paymentDate":"2020-06-19","value":20,"currency":"JPY"},{"executeDate":"2020-09-29","recordDate":"2020-09-30","paymentDate":"2020-12-01","value":21,"currency":"JPY"},{"executeDate":"2021-03-30","recordDate":"2021-03-31","paymentDate":"2021-06-01","value":21,"currency":"JPY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMF\",market:\"US\",delay:false,,,undefined,":{}}}